IperionX (ASX:IPX) said it held $77.1 million in cash as of Dec. 31, 2024, and $4.1 million was available under the Title III Defense Production Act funding in the December 2024 quarter, according to a Tuesday filing with the Australian bourse.
It said it is advancing applications for U.S. government funding, and that there is potential for accelerated review under the new administration, the filing said.
The commissioning of its titanium manufacturing campus in Virginia is progressing, and it has identified
multiple process improvements, which are expected to increase production capacity beyond nameplate levels later in the year, the filing said.
It completed the first commercial Hydrogen Assisted Metallothermic Reduction production cycle in the quarter, producing high-quality, low-oxygen titanium metal powder.
Its shares fell 3% in recent trading on Tuesday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。